U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340177) titled 'Xiaojin Pill/Neixiao Luoli Pill for the Treatment of Thyroid Nodules' on Dec. 20, 2025.
Brief Summary: The goal of this clinical trial is to learn whether Xiaojin Pill or Neixiao Luoli Pill can safely treat thyroid nodules in adults aged 18 to 65 years with benign or low-risk thyroid nodules. The main questions it aims to answer are:
* Does treatment with Xiaojin Pill or Neixiao Luoli Pill lower the size of thyroid nodules compared with lifestyle intervention alone?
* Do Xiaojin Pill or Neixiao Luoli Pill improve thyroid nodule-related symptoms and ultrasound findings while remaining safe to use?
Researchers will compare lifestyl...